Xeriant (XERI) Common Equity (2010 - 2026)

Xeriant (XERI) has 17 years of Common Equity data on file, last reported at -$2.9 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 66.04% year-over-year to -$2.9 million; the trailing twelve-month figure through Mar 2026 stood at -$2.9 million (up 66.04% YoY), and the FY2025 full-year result was -$8.7 million, down 1.02% from the prior year.
• Common Equity climbed to -$2.9 million in Q1 2026, from -$5.6 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of -$669618.0 in Q1 2022 to a low of -$8.7 million in Q2 2025.
• A 5-year average of -$6.4 million and a median of -$6.6 million in 2023 frame the typical range for Common Equity.
• Across the five-year window, Common Equity plunged 4588.35% in 2022 and soared 66.04% in 2026, its largest moves.
• Tracing XERI's Common Equity over 5 years: stood at -$5.9 million in 2022, then sank by 32.98% to -$7.8 million in 2023, then slipped by 10.72% to -$8.7 million in 2024, then soared by 35.13% to -$5.6 million in 2025, then jumped by 48.24% to -$2.9 million in 2026.
• Business Quant data shows XERI's Common Equity at -$2.9 million in Q1 2026, -$5.6 million in Q4 2025, and -$5.7 million in Q3 2025.